Claves diagnósticas | 05 OCT 05
Evaluación del paciente adulto con debilidad muscular
Es difícil distinguir la astenia y la fatiga de la debilidad muscular primaria. La ausencia de una causa evidente obliga a realizar estudios complementarios adecuados.
Autor: Dr. Saguil A. Fuente: Comentario y resumen objetivo: Dra. Marta Papponetti  Am Fam Physician. 2005 Apr 1;71(7):1327-36.
INDICE:  1. Desarrollo | 2. Bibliografía
1. Hinshaw DB, Carnahan JM, Johnson DL. Depression,  anxiety, and asthenia in advanced illness. J Am Coll Surg 2002;195:271-7.

2. Griggs RC. Episodic muscle spasms, cramps, and weakness. In: Harrison TR, Fauci AS, eds. Harrison's Principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998:118-22.

3. Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans CT, Mulrow CD, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;136:765-76.

4. Kumar A, Clark S, Boudreaux ED, Camargo CA Jr. A multicenter study of depression among emergency department patients. Acad Emerg Med 2004;11:1284-9.

5. Bannwarth B. Drug-induced myopathies. Expert Opin Drug Saf 2002;1:65-70.

6. Muscle weakness. In: Ferri FF, ed. Ferri's Clinical advisor: instant diagnosis and treatment. St. Louis: Mosby, 2003:1436.

7. Preedy VR, Adachi J, Ueno Y, Ahmed S, Mantle D, Mullatti N, et al. Alcoholic skeletal muscle myopatHi: definitions,

8. features, contribution of neuropatHi, impact and diagnosis. Eur J Neurol 2001;8:677-87.

9. Alshekhlee A, Kaminski HJ, Ruff RL. Neuromuscular manifestations of endocrine disorders. Neurol Clin 2002;20:35-58.

10. Roos, KL. Viral infections. In: Goetz CG, ed. Textbook of clinical neurology. 2d ed. Philadelphia: Saunders, 2003:895-918.

11. NosewortHi JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-52.

12. Hughes RA. Peripheral neuropatHi. BMJ 2002;324: 466-9.

13. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357:2122-8.

14. Ten S, New M, Maclaren N. Clinical review 130: Addison's disease 2001. J Clin Endocrinol Metab 2001; 86:2909-22.

15. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, et al. Treatment guidelines for patients with HipertHiroidism and HipotHiroidism. Standards of Care Committee, American THiroid Association. JAMA 1995;273:808-12.

16. Yew KS, DeMieri PJ. Disorders of bone mineral metabolism. Clin Fam Pract 2002;4:525-65.

17. Lacomis D. Electrodiagnostic approach to the patient with suspected myopatHi. Neurol Clin 2002;20:587-603.

18. Brasington RD Jr, Kahl LE, Ranganathan P, Latinis KM, Velazquez C, Atkinson JP. Immunologic rheumatic disorders. J Allergy Clin Immunol 2003;111(2 suppl):S593-601.

19. Nadeau SE. Neurologic manifestations of connective tissue disease. Neurol Clin 2002;20:151-78.

20. Lim KL, Abdul-Wahab R, Lowe J, Powell RJ. Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters. Ann Rheum Dis 1994;53:178-82.

21. Russell ML, Hanna WM. Ultrastructural pathology of skeletal muscle in various rheumatic diseases. J Rheumatol 1988;15:445-53.

22. Yazici Y, Kagen LJ. Clinical presentation of the idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002;28:823-32.

23. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 2002;28:723-41.

24. Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002;28:859-90.

25. Wortmann RL, DiMauro S. Differentiating idiopathic inflammatory myopathies from metabolic myopathies. Rheum Dis Clin North Am 2002;28:759-78.

26. Wagner KR. Genetic diseases of muscle. Neurol Clin 2002;20:645-78.

27. Pourmand R. Metabolic myopathies. A diagnostic evaluation. Neurol Clin 2000;18:1-13.

28. Bradley WG, Taylor R, Rice DR, Hausmanowa-Petruzewicz I, Adelman LS, Jenkison M, et al. Progressive myopatHi in Hiperkalemic periodic paralysis. Arch Neurol 1990;47:1013-7.

29. Comi G, Testa D, Cornelio F, Comola M, Canal N. Potassium depletion myopatHi: a clinical and morphological study of six cases. Muscle Nerve 1985;8:17-21.

30. Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin 2002;20:227-39.

31. Grauer K. A practical guide to ECG interpretation. St. Louis: Mosby, 1992.

32. Sims MH, Bell MC, Ramsey N. Electrodiagnostic evaluation of Hipomagnesemia in sheep. J Anim Sci 1980;50:539-46.

33. Vance ML. Hipopituitarism [published correction appears in N Engl J Med 1994;331:487]. N Engl J Med 1994;330:1651-62.

34. Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am 1997;81:195-219.

35. Mastaglia FL, Laing NG. Distal myopathies: clinical and molecular diagnosis and classification. J Neurol Neurosurg Psychiatry 1999;67:703-7.

36. Barnard J, Newman LS. Sarcoidosis: immunology, rheumatic involvement, and therapeutics. Curr Opin Rheumatol 2001;13:84-91.

37. Newman LS, Rose CS, Maier LA. Sarcoidosis [published correction appears in N Engl J Med 1997;337:139]. N Engl J Med 1997;336:1224-34.

38. Hull K, Griffith L, Kuncl RW, Wigley FM. A deceptive case of amyloid myopatHi: clinical and magnetic resonance imaging features. Arthritis Rheum 2001;44:1954-8.

39. Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis. Hematol Oncol Clin North Am 1999;13:1211-33.

40. Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, et al. Statin-associated myopatHi with normal creatine kinase levels. Ann Intern Med 2002;137:581-5.

41. Preston DC, Shapiro BE. Needle electromyograpHi. Fundamentals, normal and abnormal patterns. Neurol Clin 2002;20:361-96.

42. Nirmalananthan N, Holton JL, Hanna MG. Is it really myositis? A consideration of the differential diagnosis. Curr Opin Rheumatol 2004;16:684-91.


Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí